Belmora Flanax Tablet
Product Images NDC 27854-555

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Belmora Flanax (NDC 27854-555). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Belmora Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Belmora (Belmora Flanax Marksans Label 7 9 20)

This is a description of a pain reliever and fever reducer product that provides longer-lasting pain relief. There are warnings and information about allergy alert, stomach bleeding risk, heart attack & stroke risk, pregnant or breast-feeding, and directions to use. The product contains Naproxen Sodium and has 20 dual packets of 220mg tablets, with 1 tablet per packet. The product is manufactured in India and distributed by Belmora LLC, located in Arlington, VA.*

FDA Label Image

Drug Facts

FDA Label Image

Flanax 24ct Carton Marksans Proof Final

FDA Label Image

Af5e42f7 D165 0af1 E053 2995a90ac09b

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.